ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation

K. Uchida, K. Fujimoto, K. Takeda, H. Bashuda, E. Yin, K. Okumura.

Atopy(Allergy) Research Center, Juntento University, Tokyo, Japan.

Meeting: 2018 American Transplant Congress

Abstract number: D276

Keywords: Mice, Rejection, T cell activation

Session Information

Session Name: Poster Session D: Late Breaking

Session Type: Poster Session

Date: Tuesday, June 5, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Purpose: To investigate the impact of BM-MDSCs on murine heart transplantation

Material and Methods:

Bone marrow cells were harvested and cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6) for 4days to generate Gr1+ CD11b+ BM-MDSCs.

Vascularized heart from BALB/c mice was transplanted into the abdomen of C57BL/6 mice. Five million of BM-MDSCs was injected to transplanted mice immediately, 24 and 72 hours after transplantation. Graft survivals were compared to syngeneic and allogeneic control grafts.

Results: Ly6Glow-Ly6Chi monocytic MDSC were mainly generated and suppressed T cell activation via arginase I. Graft survival was significantly prolonged in BM-MDSCs group compared with allogeneic transplants (MST 37.2days vs 10days, p<0.05 t-test ). The number of infiltrated CD8+ and CD4+ Tcell in graft was also significantly lower in BM-MDSCs group. INF-γ and Granzyme B mRNA expression in graft were significantly decreased and foxp3 expression increased in BM-MDSCs group. Injected BM-MDSCs were not found neither spleen nor lymph node at 7 days after transplantation.

Conclusions: BM-MDSCs therapy is a potential option to protect graft rejection in organ transplantation.

CITATION INFORMATION: Uchida K., Fujimoto K., Takeda K., Bashuda H., Yin E., Okumura K. Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Uchida K, Fujimoto K, Takeda K, Bashuda H, Yin E, Okumura K. Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/bone-marrow-derived-myeloid-suppressor-cell-bm-mdscs-prolongs-the-graft-survival-in-murine-heart-transplantation/. Accessed May 9, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences